News coverage about iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB) has trended somewhat positive recently, Accern reports. Accern scores the sentiment of media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. iShares Nasdaq Biotechnology Index Fund earned a media sentiment score of 0.19 on Accern’s scale. Accern also gave news stories about the financial services provider an impact score of 45.1543573081578 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
These are some of the news stories that may have impacted Accern Sentiment’s scoring:
- CA governor expected to sign drug pricing bill today (finance.yahoo.com)
- IBB – A Clearer Runway Ahead (ino.com)
- What Is Going On With Micro-Caps? (talkmarkets.com)
- Traders Buy High Volume of iShares Nasdaq Biotechnology Index Fund Call Options (IBB) (americanbankingnews.com)
- Big biotech trades: 5 plays (finance.yahoo.com)
Shares of iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB) opened at 339.59 on Wednesday. iShares Nasdaq Biotechnology Index Fund has a one year low of $246.71 and a one year high of $342.50. The stock has a 50 day moving average price of $330.38 and a 200 day moving average price of $309.12.
The company also recently declared a quarterly dividend, which was paid on Friday, September 29th. Stockholders of record on Wednesday, September 27th were given a dividend of $0.119 per share. This represents a $0.48 annualized dividend and a dividend yield of 0.14%. The ex-dividend date was Tuesday, September 26th.
About iShares Nasdaq Biotechnology Index Fund
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Receive News & Ratings for iShares Nasdaq Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.